I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Dry Macular Degeneration: What It Is and How to Protect Your Vision
What Is Dry Macular Degeneration?
Dry AMD is a chronic eye condition that affects a small but critical part of the eye called the macula. Understanding how it develops and how it compares to other forms of AMD helps you take a more active role in your care.
The macula is a small area located at the center of the retina, which is the light-sensitive tissue lining the back of the eye. Although the macula is tiny, it is responsible for your central vision, meaning the sharp, detailed sight you use to read, recognize faces, and see fine details clearly. When the macula is affected by disease, your peripheral (side) vision may stay intact, but the clarity you depend on most begins to fade.
Dry AMD occurs when small yellow deposits called drusen build up beneath the retina. Drusen are made of lipids (fats) and proteins. A small number of drusen are a normal part of aging, but when they become larger or more numerous, they signal early or intermediate AMD. Over time, the light-sensitive cells in the macula thin and gradually break down, causing the slow, progressive loss of central vision that defines this condition.
Retina specialists classify dry AMD into three stages based on the size and number of drusen present and any visible changes in the cells supporting the retina.
- Early dry AMD: Medium-sized drusen are present, but most people notice no vision changes at this stage.
- Intermediate dry AMD: Large drusen or pigment changes in the retina are present. Some people notice mild blurriness or difficulty seeing in dim light.
- Late dry AMD, also called geographic atrophy: Significant loss of retinal cells and supporting tissue has occurred, causing noticeable central vision loss.
Knowing your stage helps your retina specialist determine the right monitoring schedule and whether any treatment is appropriate for you.
There are two forms of age-related macular degeneration. Dry AMD accounts for the large majority of all cases, and it causes the macula to thin slowly over time. Wet AMD is less common but more aggressive. It develops when abnormal blood vessels grow beneath the retina and leak fluid or blood, which can cause sudden and significant vision changes. Dry AMD can convert to wet AMD at any stage, which is one of the most important reasons to maintain regular monitoring even when your vision feels stable.
Who Is at Risk for Dry AMD
Dry AMD is one of the leading causes of vision loss in adults over 50. Knowing your personal risk factors can help motivate earlier screening and protective steps that may slow its development.
Age is the single strongest risk factor. Dry AMD is most common in people over 55, and risk increases significantly after age 65. Genetics also play an important role. People with a parent or sibling who has AMD are at higher risk of developing it themselves. Certain gene variants, particularly in the complement factor H (CFH) gene and the ARMS2 gene, have been strongly linked to increased AMD risk. If AMD runs in your family, let your eye care provider know so that earlier or more frequent screening can be arranged.
Several risk factors are within your control, and addressing them may help slow the development or progression of dry AMD.
- Smoking: Current smokers are significantly more likely to develop AMD than nonsmokers, and risk decreases over time after quitting.
- Diet: Eating few leafy green vegetables, fish, or antioxidant-rich foods may increase risk.
- Obesity: A higher body mass index has been associated with faster AMD progression.
- Sun exposure: Prolonged ultraviolet light exposure over a lifetime may contribute to retinal damage.
- Cardiovascular health: High blood pressure and heart disease are associated with a higher risk of AMD.
Even modest, consistent changes in these areas can contribute to better long-term outcomes for your macular health.
Dry AMD is diagnosed more commonly in white Americans compared to Black, Hispanic, or Asian Americans, though it can affect anyone. Women are diagnosed with AMD more frequently than men, likely in part because women tend to live longer on average. Regardless of background or gender, anyone over 50 should have regular comprehensive eye exams that include an evaluation of the macula.
Signs and Symptoms of Dry AMD
One of the most challenging aspects of dry AMD is that it often develops without any noticeable symptoms in its earlier stages. Knowing what to watch for helps you seek care at the right time and avoid preventable vision loss.
In the early stages, most people with dry AMD are completely unaware that anything is wrong. The drusen that accumulate beneath the retina are too small to cause noticeable vision changes at first. This is why dry AMD is so often detected during a routine dilated eye exam before any symptoms appear. Waiting until something feels wrong means losing valuable time for early monitoring and intervention.
As dry AMD advances toward geographic atrophy, symptoms become more apparent. You may notice blurriness in your central field of vision, difficulty reading even with your correct prescription, or trouble seeing clearly in low lighting. In more advanced stages, blank or dark spots may appear in the center of your vision, straight lines may look wavy or distorted, and colors may seem less vivid than they once did. These changes typically develop gradually over months or years, though progression can sometimes be faster.
Because early dry AMD causes no symptoms, comprehensive eye exams are your best tool for early detection. The American Academy of Ophthalmology recommends a baseline eye exam at age 40 and more frequent exams after age 65. People with known risk factors may benefit from exams more often. Detecting dry AMD early gives our team the best opportunity to monitor changes closely and recommend steps to slow progression before meaningful vision loss occurs.
How We Diagnose Dry AMD
We use a combination of clinical examination and advanced imaging to confirm a diagnosis, understand which stage you are in, and track any changes over time with precision.
A dilated eye exam is the standard first step in evaluating dry AMD. During this exam, we place drops in your eyes to widen the pupils, which allows us to view the macula and surrounding retina directly. We look for drusen, pigment changes, and any early signs of atrophy. The exam is painless and gives us important foundational information about your retinal health before any imaging is performed.
Optical coherence tomography, known as OCT, is a noninvasive imaging test that produces detailed, cross-sectional pictures of the retinal layers. It allows us to measure retinal thickness, identify drusen beneath the retinal surface, detect any fluid, and spot thinning of specific layers that may not be visible during a standard exam. OCT is one of our most important tools for tracking AMD progression over time and is performed routinely at follow-up visits.
Fundus photography produces high-resolution color images of the retina that help document its appearance and detect changes between visits. Fundus autofluorescence (FAF) imaging uses a specialized camera to detect metabolic changes in the retinal pigment epithelium, which is the layer of cells that supports the retina from beneath. FAF is particularly useful for mapping the location and boundaries of geographic atrophy. Together, these imaging tools give us a detailed and precise record of how your condition is changing.
An Amsler grid is a simple paper tool you can use at home to monitor your central vision between appointments. It consists of evenly spaced horizontal and vertical lines with a small dot at the center. To use it, cover one eye at a time, focus on the center dot, and note whether any lines appear wavy, blurry, or missing. If you notice any new or worsening changes, contact us promptly. These changes may signal progression of dry AMD or a conversion to wet AMD, both of which require timely evaluation.
Treatment Options for Dry Macular Degeneration
There is currently no treatment that reverses dry AMD or restores vision that has already been lost. However, several well-supported approaches can help slow progression and protect the vision you have. Your retina specialist will recommend options based on your specific stage and overall health.
The Age-Related Eye Disease Studies, known as AREDS and AREDS2, were landmark clinical trials conducted by the National Eye Institute. The AREDS2 trial found that a specific combination of vitamins and minerals reduced the risk of progressing from intermediate dry AMD to the late stage by approximately 25 percent. The AREDS2 formula includes vitamin C, vitamin E, lutein, zeaxanthin, zinc, and copper, and it is available over the counter at most pharmacies.
These supplements are not a cure and will not improve vision that has already been affected. They are specifically recommended for people with intermediate dry AMD or advanced AMD in one eye, as a way to reduce the risk of further progression. Your retina specialist can advise whether this formula is appropriate for your situation and whether it could interact with any medications you already take.
Geographic atrophy is the advanced stage of dry AMD in which retinal cells are progressively and permanently lost. For the first time, FDA-approved treatments exist specifically for this stage. These medications work by targeting the complement system, which is a part of the immune system that contributes to the destruction of retinal cells in geographic atrophy. They are administered as intravitreal injections, meaning they are delivered directly into the eye during a brief in-office procedure.
These treatments do not restore vision that has been lost, but clinical studies have shown that they can significantly slow the rate at which geographic atrophy expands. Slowing this expansion may help preserve remaining central vision for a longer period. Your retina specialist will evaluate whether you are a candidate and will discuss the expected benefits, risks, and schedule in detail.
Certain lifestyle changes are supported by clinical evidence as meaningful ways to reduce AMD risk and slow its progression over time.
- Stop smoking: Quitting is one of the most impactful steps you can take. Risk decreases progressively in the years following cessation.
- Eat a nutrient-rich diet: Foods high in lutein and zeaxanthin, such as kale, spinach, and eggs, support macular health. Omega-3 fatty acids from fish may also be beneficial.
- Exercise regularly: Moderate physical activity has been linked to lower AMD risk and slower progression.
- Protect your eyes from UV light: Wear sunglasses that block both UVA and UVB rays whenever you are outdoors.
- Manage cardiovascular health: Keeping blood pressure and cholesterol in a healthy range supports overall eye health.
These steps are most effective when maintained consistently over years, and they complement any clinical treatments your specialist recommends.
For people who have experienced significant central vision loss from advanced dry AMD, low vision rehabilitation can help maximize the vision that remains. Low vision specialists can recommend tools such as magnifying lenses, large-print materials, screen readers, voice-activated technology, and specialized lighting. These resources help many people continue reading, using computers, and managing daily tasks with greater independence. We can provide referrals to low vision services as part of your broader care plan when appropriate.
Living With Dry Macular Degeneration
Dry AMD is a long-term condition, but most people live full, active lives with proper care, consistent follow-up, and practical adjustments. Understanding what to expect makes day-to-day management much more manageable.
Dry AMD is a chronic, slowly progressing condition. In many people, progression takes years or even decades. Some individuals with early dry AMD never advance to more severe stages, while others may progress to intermediate AMD or geographic atrophy over time. The rate of progression varies significantly from person to person and depends on genetics, lifestyle, and the specific characteristics of the drusen present at diagnosis. Regular follow-up allows us to detect any changes in pace early and adjust your care accordingly.
Ongoing visits with your retina specialist are essential for managing dry AMD well. How often you need to be seen depends on your stage. People with early dry AMD may be seen once a year, while those with intermediate or advanced AMD typically need appointments every three to six months. At each visit, we perform imaging to assess for changes, including signs that geographic atrophy is expanding or that a conversion to wet AMD may be occurring. Consistent follow-up is what makes proactive, timely management possible.
Small changes to your environment and daily habits can make a meaningful difference in managing vision changes. Increasing lighting throughout your home, especially in reading areas and the kitchen, makes detail work easier. Using e-readers with adjustable font sizes or large-print books helps with reading. High-contrast display settings on phones and computers improve screen visibility. Organizing your home to reduce clutter and trip hazards protects your safety as central vision changes over time.
A diagnosis of macular degeneration can feel frightening, especially if you worry about losing independence or the ability to do things you love. These concerns are completely understandable. It is reassuring to know that most people with dry AMD retain useful vision for many years, particularly with consistent monitoring and management. Support groups, counseling, and low vision services can all help you adapt to changes and maintain your quality of life. You do not have to face this alone, and our team is here to support you at every stage.
When to Seek Care
Knowing when to schedule a routine appointment versus when to seek urgent evaluation can make a meaningful difference in protecting your vision long term.
Anyone over the age of 50 should have regular comprehensive eye exams that include a macula evaluation. If you have a family history of AMD, a smoking history, or other known risk factors, talk to your eye care provider about beginning screening earlier or scheduling exams more frequently. Early detection is one of the most powerful tools available, because monitoring and preventive measures are most effective when the disease is identified at an earlier stage.
Certain vision changes should not wait for a scheduled appointment. Contact our office right away or seek emergency evaluation if you experience any of the following.
- A sudden increase in floaters, which are spots, strings, or cobwebs drifting through your vision
- Flashes of light in one or both eyes
- A dark curtain, shadow, or veil moving across any part of your visual field
- Sudden blurring or loss of central vision
- Sudden distortion where straight lines appear wavy or bent
These symptoms may indicate a conversion from dry to wet AMD or another serious retinal condition. Prompt evaluation and treatment can be the difference between preserving vision and experiencing permanent loss.
Frequently Asked Questions
Below are answers to questions we frequently hear from patients managing dry AMD. If something is not addressed here, our team is always glad to talk it through with you.
Currently, there is no treatment that can reverse dry AMD or restore central vision that has already been lost. The focus of care is on slowing progression and preserving the vision you still have. Whether AREDS2 supplements, complement inhibitor injections, or lifestyle changes are appropriate for you depends on your specific stage of disease. Your retina specialist will evaluate your imaging results at each visit and guide you toward the options most likely to benefit your individual situation.
The injection schedule for geographic atrophy treatments depends on the specific medication your specialist recommends and how your eye responds over time. Some medications are given monthly, while others may be administered every several weeks based on clinical protocols. These injections are performed in the office and typically take only a few minutes. Many patients find the process manageable once they understand what to expect, and our team walks you through each step.
Most people with dry AMD do not lose all of their vision. Dry AMD primarily affects central vision, but peripheral (side) vision is typically preserved even in advanced stages. This means most people retain enough vision to navigate their surroundings and maintain a meaningful degree of independence. Low vision rehabilitation can help you make the most of remaining vision. Total blindness from dry AMD alone is uncommon, though advanced disease in both eyes can significantly limit fine-detail tasks.
The AREDS2 formula is well tolerated by most people, but it is not right for everyone. An earlier version of the formula contained beta-carotene, which was associated with an increased risk of lung cancer in people who currently smoke or have smoked. The updated AREDS2 formula replaced beta-carotene with lutein and zeaxanthin, making it safer for a broader range of patients. Even so, you should always discuss any supplement use with your retina specialist and your primary care provider, especially if you take other medications or have other health conditions that could interact with the ingredients.
Drusen are the yellow deposits that build up beneath the retina and serve as the hallmark of early and intermediate dry AMD. Having drusen does not automatically mean you will lose significant vision, but their size and density help your specialist predict the likelihood and pace of progression. Geographic atrophy is a fundamentally different and more advanced stage. It refers to areas where retinal cells and the supporting tissue beneath them have permanently died, creating irreversible areas of central vision loss. Tracking the transition from drusen to early atrophy is one of the primary reasons we schedule regular imaging visits, because catching that change early allows us to act sooner.
Whether you can safely drive depends on how much your central vision has been affected and whether both eyes are involved. Many people with early or intermediate dry AMD continue to drive without difficulty. As the condition progresses, particularly when both eyes are affected, reduced clarity or central blind spots may begin to interfere with safe driving. Your retina specialist can give you an honest assessment of how your current vision affects your ability to drive safely. If driving becomes unsafe at some point, our team can connect you with low vision resources and discuss strategies that support your continued independence.
Expert Retina Care Close to Home
At New England Retina Associates, our fellowship-trained vitreoretinal surgeons are dedicated to providing thoughtful, expert care for patients with dry AMD and other retinal conditions throughout Connecticut. Whether you have been referred by your eye doctor or are reaching out on your own, we welcome you and are committed to helping you understand your diagnosis, protect your vision, and feel supported through every step of your care. We invite you to schedule an appointment at any of our conveniently located offices.
30 Years of Care & Commitment
